These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11741210)

  • 1. Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine.
    Ren S; Slatterly JT
    AAPS PharmSci; 1999; 1(3):E14. PubMed ID: 11741210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein.
    Ren S; Kalhorn TF; Slattery JT
    Drug Metab Dispos; 1999 Jan; 27(1):133-7. PubMed ID: 9884322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA; van Ommen B; van Bladeren PJ
    Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
    Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N; Chen J; Yoshida A
    Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2).
    Quash G; Fournet G; Chantepie J; Gore J; Ardiet C; Ardail D; Michal Y; Reichert U
    Biochem Pharmacol; 2002 Oct; 64(8):1279-92. PubMed ID: 12234608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study.
    Adams DM; Zhou T; Berg SL; Bernstein M; Neville K; Blaney SM;
    Pediatr Blood Cancer; 2008 Mar; 50(3):549-53. PubMed ID: 17941066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.
    Peták I; Mihalik R; Bauer PI; Süli-Vargha H; Sebestyén A; Kopper L
    Cancer Res; 1998 Feb; 58(4):614-8. PubMed ID: 9485009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group.
    McCune JS; Salinger DH; Vicini P; Oglesby C; Blough DK; Park JR
    J Clin Pharmacol; 2009 Jan; 49(1):88-102. PubMed ID: 18927240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
    Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
    J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea).
    Shinohara K; Tanaka KR
    Clin Chim Acta; 1979 Mar; 92(2):147-52. PubMed ID: 39688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCC2-mediated biliary transport of 4-glutathionylcyclophosphamide and its contribution to elimination of 4-hydroxycyclophosphamide in rat.
    Qiu R; Kalhorn TF; Slattery JT
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1204-12. PubMed ID: 14617693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects.
    Jones RB; Stockerl-Goldstein KE; Klein J; Murphy J; Blume KG; Dansey R; Martinez C; Matthes S; Nieto Y
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):276-82. PubMed ID: 15077226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme.
    Bunting KD; Townsend AJ
    J Biol Chem; 1996 May; 271(20):11891-6. PubMed ID: 8662659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.